Trino Therapeutics is a developer of anti-inflammatory drugs, specifically focusing on a novel class of drugs based on the indane skeleton derived from a Taiwanese fern
Trino Therapeutics is a developer of anti-inflammatory drugs, specifically focusing on a novel class of drugs based on the indane skeleton derived from a Taiwanese fern. The company's lead candidate is a potential first-in-class drug for the treatment of inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease.